eXIthera

0 followers


eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk of bleeding.

Industries

Headquarters

Stage

Employees

Links

Neil J. Hayward
CEO, President, & Co-Founder

Neil J. Hayward

Collapse
Michael Kurz
VP, Translational Medicine & Medical Affairs
Paula M. Bokesch
Head, Clinical Development
Bert L. Chenard
Head, Chemistry
Priya Jambhekar
Head, Regulatory Affairs
Andy Hu
Head, Corporate & Business Development
William Koster
Director (Chairman)